Feds approve Regeneron, Sanofi skin cancer drug
October 01, 2018 at 07:50 AM EDT
Drug makers Regeneron Pharmaceuticals and Sanofi have won federal approval to make a skin cancer medication for patients who do not respond to surgery or radiation.